Health

Johnson & Johnson Innovation Announces Collaboration with Singapore Economic Development Board to Help Transform Singapore's Life Science Innovation Ecosystem

The first-of-its-kind collaboration will embed the services and resources of Johnson & Johnson Innovation - JLABS intoSingapore's life science ecosystem to unlock regional innovation potential. SINGAPORE, Sept. 26, 2023 /PRNewswire/ -- Johnson & Johnson International ( Singapore) Pte. Ltd. today ...

2023-09-26 06:30 2318

The 88th CMEF in Shenzhen Set to Spotlight Advancements in the Medical Equipment Industry

SHENZHEN, China, Sept. 25, 2023 /PRNewswire/ -- The China International Medical Equipment Fair (CMEF), organized by Reed Sinopharm Exhibitions, serves as an excellent bridge for brands aiming to enter the Chinese market. The 88th edition of this prestigious medical event is scheduled to take plac...

2023-09-25 21:00 3175

Chime Biologics Enters into a Strategic Cooperation Agreement with Korea Kings Pharm to Accelerate the Biosimilar Launch

* Chime Biologics has entered into a strategic collaboration with Kings Pharm for a biosimilar asset, providing cell line development, process development, global GMP manufacturing, commercialization and regulatory filing support. Chime will also supply the commercial production once the produc...

2023-09-25 20:15 1426

Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients

SHANGHAI, Sept. 25, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced the introduction of its Patient-Reported Outcome (PRO) -based sy...

2023-09-25 20:00 1357

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

SINGAPORE, Sept. 25, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore -based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor-derived cell-based allogeneic immunothera...

2023-09-25 19:00 1443

Xtep Unveils Milestone Brand Strategy Upgrade to Offer World-Class Running Shoes and Gears

Xtep's international roadmap sprints for win-win success with global partners BEIJING, Sept. 25, 2023 /PRNewswire/ -- Xtep International Holdings Limited ("Xtep"), a leading professional sportswear company, has launched its milestone brand strategy upgrade of "World-class Running Shoes of China X...

2023-09-25 18:48 1968

EQT PRIVATE EQUITY TO SELL LIMACORPORATE TO ENOVIS: THE ITALIAN SITE IN SAN DANIELE DEL FRIULI WILL REMAIN THE FULCRUM OF PRODUCTION, BENEFITING FROM NEW INVESTMENTS

UDINE, Italy, Sept. 25, 2023 /PRNewswire/ -- EQT Private Equity announces the sale of LimaCorporate to Enovis. With this transaction, LimaCorporate will become part of the NYSE-listed Enovis group in a strategic combination that creates a global leader in the orthopaedic industry. Founded in 194...

2023-09-25 18:01 1970

Huawei Accelerates Intelligent Healthcare with the Innovative Digital Medical Technology Solution

SHANGHAI, Sept. 25, 2023 /PRNewswire/ -- During HUAWEI CONNECT 2023, Huawei held the first intelligent healthcare summit themed "Build a Digital Health Community to Accelerate Intelligent Healthcare". Huawei released the Digital Medical Technology Solution to help the healthcare industry go smart...

2023-09-25 15:35 2101

"Kexing Biopharm 2023 Innovation Forum on Targeted Drug Delivery"

SHENZHEN, China, Sept. 25, 2023 /PRNewswire/ -- On September 15, "Kexing Biopharm 2023 Innovation Forum on Targeted Drug Delivery" successfully kicked off. This marks the first time in recent years that the Company has organized an event specifically focused on pharmaceutical R&D innovation. The...

2023-09-25 15:31 1974

Pierre Fabre Laboratories and Vernalis announce a drug discovery collaboration in oncology

CASTRES, France and CAMBRIDGE, England, Sept. 25, 2023 /PRNewswire/ -- Pierre Fabre Laboratories and Vernalis (R&D) Ltd ("Vernalis"), a fully owned subsidiary of HitGen Inc., are pleased to announce a long-term partnership to identify pre-clinical candidates against multiple oncology targets.   ...

2023-09-25 15:00 1441

Power Up with Energizer's Re-Energize 100% Fitfest this October

Open For Individuals Aged 13 And Above, The 3-Day Fitness-Packed Fest Is Now Open For Registration And Give Your Car The Finish It Deserves At Armor All Carwash Section KUALA LUMPUR, Malaysia, Sept. 25, 2023 /PRNewswire/ -- Energizer Malaysia announcesRe-Energize 100% Fitfest, a power-packed fit...

2023-09-25 11:48 2048

'Bayer For Her' Supporting 365 Days Conversations of Care to More Women in Asia

* Bridging the gap on lack of discussion amongst Asian women on their health concerns this World Contraception Day (WCD) SINGAPORE, Sept. 25, 2023  /PRNewswire/ -- Bayer Pharmaceuticals Division inAsia/Pacific announced today in conjunction with World Contraception Day, the inception of its 'Ba...

2023-09-25 09:56 2237

AffaMed Therapeutics Announces Clinical Trial Application Approval in Mainland China for Risuteganib (Luminate®) First-in-Class Candidate for the Treatment of Intermediate Dry AMD

SHANGHAI, Sept. 25, 2023 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmological, neurological and psychi...

2023-09-25 09:00 2396

ASTRAZENECA AND INSTITUT KANSER NEGARA PARTNER TO INTRODUCE AI TECHNOLOGY FOR LUNG SCREENING

The partnership paves the way for the adoption of AI technology in chest x-ray for early lung screening at government health facilities KUALA LUMPUR, Malaysia, Sept. 22, 2023 /PRNewswire/ -- In conjunction with Institut Kanser Negara's (IKN) 10th anniversary, AstraZeneca announced its collaborat...

2023-09-25 09:00 2638

Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC

SHANGHAI, Sept. 25, 2023 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696. HK) announced that the new drug application (NDA) for new indication of HANSIZHUANG (serplulimab injection), an innovative anti-PD-1 monoclonal antibody independently developed by the company, in combination with drugs...

2023-09-25 07:41 1907

MediLink Therapeutics: Focuses on ADC research and development to promote new prospects for cancer treatment

----- YL201 Phase I/II Investigators Meeting was successfully held in Guangzhou, China GUANGZHOU, China, Sept. 23, 2023 /PRNewswire/ -- On September 23, 2023, oncologists and experts from more than 60 clinical research centers across the country gathered inGuangzhou to participate in the YL201 P...

2023-09-23 18:29 2534

Concord Medical Reports Financial Results for the First Half of 2023

BEIJING, Sept. 22, 2023 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extens...

2023-09-23 05:00 5557

Biomerics Announces Completion of 100,000 sq. ft. Expansion of Brooklyn Park, MN, Facility

SALT LAKE CITY, Sept. 22, 2023 /PRNewswire/ -- Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced the completion of a 100,000-square-foot expansion of their operations inBrooklyn Park, Minnesota, bringing the facility ...

2023-09-22 22:03 2075

Chime Biologics Announced Global Strategic Cooperation with Panolos Bioscience to Advance Multi-specific Therapeutic Proteins Development

* Chime Biologics and Panolos Bioscience have entered into a global strategic collaboration agreement on a novel multi-specific protein drug. Chime Biologics will provide development and manufacturing services to Panolos Bioscience for PB203, a next-generation immuno-oncology drug. WUHAN, China...

2023-09-22 20:15 1565

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

FOSTER CITY, Calif., Sept. 22, 2023 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, today announced that the U.S. Food and Drug Administration (FDA) has g...

2023-09-22 16:41 1397
1 ... 161162163164165166167 ... 847